Is this your Brand? Log in to Hoodie!
Log in to HoodieTheraplant
Data Snapshot for Mar 20, 2026
Overview
Theraplant is a CT State-Licensed marijuana producer dedicated to helping patients live & feel better. In September 2014, we were the first producer to release cannabis onto the Connecticut market. We hand select premium cannabis genetics to offer a variety of different THC and C...
THERAPLANT's YoY growth plummeted 57.1%, dropping from #1 to #2 in Connecticut, signaling a critical shift in market dynamics. Sales decreased 33.2% over the last three months, showcasing significant challenges ahead.
Categories
- Top Category: Vapes
- Price Tier: Premium
- States Active: 1
Top States
Theraplant Top StatesFeb 2026
Top states where Theraplant is active based on indexed sales coverage.
Trend View
Market Insights SnapshotFeb 2026
Trend narrative unavailable.
24-Month Trend
Average Price
$40.12
YoY Sales Trend
57.1%
2Y Sales Trend
64.1%
Vapes dominate at 37.1% but are down 74.9% YoY. Flower is a bright spot at +10.3% YoY, while Concentrates lead with a remarkable +67.3% YoY growth, revealing shifting consumer preferences.
| Category | Sales Share | Avg Price | YoY |
|---|---|---|---|
| Vapes | 37.1% | $46.05 | 74.9% |
| Flower | 32.8% | $50.29 | 10.3% |
| Pre-Rolls | 17.7% | $25.35 | 48.9% |
| Oral | 9.6% | $36.78 | 29.3% |
| Concentrates | 2.3% | $38.71 | 67.3% |
THERAPLANT maintains a concentrated presence in Connecticut, accounting for 100% of sales in a single-state operation. This geographic focus presents both risks and opportunities.
| State | Concentrates | Flower | Oral | Pre-Roll | Vapes |
|---|---|---|---|---|---|
| 3 | 3 | 1 | 2 | 2 |
Want SKU-Level Buyer Signals?
Unlock purchaser contacts, SKU-level velocity, and whitespace opportunities for this brand.
Market Position
Competitive LandscapeFeb 2026
#2 in the Vapes category, trailing SELECT. THERAPLANT has lost ground, falling from #1, while facing stiff competition from CTPHARMA and ADVANCED GROW LABS.
SKU View
Notable ProductsFeb 2026
Top products for Feb 2026 with sales and momentum indicators.
| Product | Category | MoM |
|---|---|---|
#1  | Vapes | 23.3% |
#2  | Oral | 20.5% |
#3  | Flower | 86.8% |
#4  | Vapes | N/A |
#5  | Flower | 6.2% |
#6  | Vapes | 293.8% |
#7  | Vapes | 1055.7% |
#8  | Pre-Rolls | 222.8% |
#9  | Flower | 264.9% |
#10  | Pre-Rolls | 332.5% |
Benchmarking
Competitive Peer Set
Peer brands benchmarked against Theraplant using competitive landscape rank coverage, proximity, and momentum.
